Hepatitis C Current Events | Hepatitis C News | 5
|
| Page
5 of
11 |
218 Results |
|
|
|
Sort By:
Page Views | Date |
Edible vaccine for Hepatitis B
Edible Vaccines may play a big part in the future for protection against Hepatitis B infection. Professor Yasmin Thanavala, from Roswell Park Cancer Institute, USA, describes her research at the British Society for Immunology's Congress 2000 in Harrogate today (Wednesday 6 December 2000). The hepatitis B virus has infected more than 2 billion... view more... (2000-12-01)
Cellular antacids give vaccines a boost
Scientists in Italy have found that a drug that blocks acid buildup inside cells revs up the immune response to vaccines. view more (2005-09-12)
Hepatitis C responds best to combo of ribavirin and interferon, study concludes
A combination of the drugs ribavirin and interferon is more effective in treating hepatitis C than using interferon alone, but it also increases the risk of side effects, according to a new systematic review of recent evidence. view more (2005-07-20)
UQ research heralds vaccine technology breakthrough
Respiratory syncytial virus (RSV) infection is a widespread infant illness that has been linked to asthma and can be deadly but may be curable by the development of this new vaccine technology by the Sir Albert Sakzewski Virus Research Centre and The University of Queensland's Faculty of Biological and Chemical Sciences. view more (2007-05-09)
Number of cases of most vaccine-preventable diseases in US at all-time low
A comparison of illness and death rates for 13 vaccine-preventable diseases in the U.S., before and after use of the vaccine, indicates there have been significant decreases in the number of cases, hospitalizations and deaths for each of the diseases examined. view more (2007-11-14)
Study details hepatitis C ability to block immune system response
Hepatitis C virus (HCV) is a worldwide public health problem. The World Health Organization estimates that 170 million people worldwide are chronically infected and that between 3-4 million are newly infected annually. view more (2006-05-19)
Needle-free immunizations
Samir Mitragotri, a professor of chemical engineering at the University of California, Santa Barbara, says the myriad shortcomings of injections have led to active research and development of needle-free methods of immunization. view more (2005-12-02)
Drug boosts platelets in hepatitis C patients
It's not a cure, but this may be some of the best news patients infected with the hepatitis C virus (HCV) have heard in a long time: A new drug, eltrombopag, appears to be effective in boosting low platelet counts, one of the major reasons why patients can't endure antiviral treatments. view more (2007-11-29)
Discovery could lead to a new animal model for hepatitis C
During its career, the potentially fatal hepatitis C virus has banked its success on a rather unusual strategy: its limitations. Its inability to infect animals other than humans and chimpanzees has severely hampered scientists in developing a useful small animal model for the disease. view more (2009-01-29)
Mild hepatitis C infection will rapidly worsen in one in three people affected
Mild hepatitis C infection will rapidly worsen in one in three of those affected, suggests research in Gut. This is particularly likely in those who are older when first infected, and those who already have a degree of inflammation and scar tissue (fibrosis) in their liver at diagnosis. The viral liver infection hepatitis C (HCV) is mainly passed... view more... (2004-02-11)
LIAI scientists make major advance in the fight against chronic virus infections
A major finding that could lead to a new approach for treating hepatitis C and other chronic virus infections was announced today by researchers at the La Jolla Institute for Allergy & Immunology (LIAI). view more (2006-10-10)
Scientists call for Hepatitis treatment of young injection drug users
In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV). view more (2006-02-07)
New drug helps hepatitis C patients start antiviral therapy
A new drug that stimulates the production of blood platelets can enable patients infected with hepatitis C virus to take other antiviral medications they previously could not take to fight the disease, according to the results of a clinical trial led by a Duke University Medical Center researcher. view more (2006-10-31)
An unexpected link between coronavirus replication and protein secretion in infected cells
Coronavirus replication is critically linked to two factors within the early secretory pathway, according to new findings by a team of Dutch researchers that are published June 13th in the open-access journal PLoS Pathogens. view more (2008-06-13)
Interferon as long-term treatment for hepatitis C not effective, report HALT-C researchers
Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern Medical Center researchers and their colleagues from nine other institutions have found in a multicenter study. view more (2008-12-05)
Scripps research team identifies key molecules that inhibit viral production
The research, led by Professor Donny Strosberg of Scripps Florida, was published on March 4, 2009, in the Journal of General Virology's advance, online edition, Papers in Press. In the new study, Strosberg and his colleagues describe peptides (molecules of two or more amino acids) derived from the core protein of hepatitis C. The team found that... view more... (2009-03-11)
Doctors call for balancing of patient/carer viral transmission protection.
Healthcare staff are at a much higher risk of acquiring viral infections from infected patients than vice versa. These viral infections include HIV and hepatitis. Despite this, patients receive enormous protection, while staff could be left exposed. A paper published this week in the British Journal of Surgery recommends that good medical care of... view more... (2004-03-15)
For Stanford scientists, RNAi gene therapy takes two steps forward, one step back
Three years ago Mark Kay, MD, PhD, published the first results showing that a hot new biological phenomenon called RNA interference was an effective gene-therapy technique in mice. view more (2006-05-25)
MIT: Why men are more prone to liver cancer
A fundamental difference in the way males and females respond to chronic liver disease at the genetic level helps explain why men are more prone to liver cancer, according to MIT researchers. view more (2008-01-16)
Study finds Canada's supervised injection facility cost-effective
Canada's only supervised injection facility is extending lives and saving the health-care system millions of dollars, a new study shows. view more (2008-11-18)
|
|
| Page
5 of
11 |
218 Results |
|
|
|
Sort By:
Page Views | Date |
|
